Bayer 20414: A multicenter, non-randomized, open-label, multiple dose escalation study to evaluate thesafety and tolerability of subcutaneous BAY 1093884 in males with hemophilia

Project: Research project

Project Details

Description

Bayer 20414: A multicenter, non-randomized, open-label, multiple dose escalation study to evaluate the safety and tolerability of subcutaneous BAY 1093884 in males with hemophilia
StatusActive
Effective start/end date3/11/193/30/24

Funding

  • BAYER HEALTHCARE PHARMACEUTICALS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.